PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 296.7K (Avg.)
-1.36 | -1.31
View analysts' price targets and recommendations, and compare them with competitors.
$11.07
Analysts expect the stock price to increase by 521.91%.
Buy
Positive consensus among analysts.
Analyze analyst forecasts for the company and compare them with competitors.
1.17M
Worse than ADAP's estimated revenue of 9.20M.
-234.73K
Better than ADAP's estimated ebitda of -9.20M.
-1.16
Worse than ADAP's estimated eps of -0.03.
-30.77M
Worse than ADAP's estimated net income of -6.43M.
-234.73K
Better than ADAP's estimated ebit of -9.20M.
43.49M
Better than ADAP's estimated sg&a expense of 115.28M.
Analyze DCF forecasts for the company and compare them with competitors.
No Data
No DCF data available for this metric in the selected year.
No Data
No DCF data available for this metric in the selected year.
-21.77M
Better than ADAP's ebitda of -125.81M.
100.00%
Better than ADAP's ebitda margin of -3178.65%.
-22.21M
Better than ADAP's ebit of -133.46M.
100.00%
Better than ADAP's ebit margin of -3372.01%.
447.00K
Better than ADAP's depreciation of 7.65M.
63.56M
Worse than ADAP's total cash of 368.22M.
100.00%
Worse than ADAP's cash as percentage of revenue of 9303.11%.
No Data
No DCF data available for this metric in the selected year.
100.00%
Worse than ADAP's receivables as percentage of revenue of 3.51%.
No Data
No DCF data available for this metric in the selected year.
100.00%
Worse than ADAP's inventories as percentage of revenue of 52.70%.
4.34M
Better than ADAP's accounts payable of 6.39M.
100.00%
Better than ADAP's payables as percentage of revenue of 161.42%.
-253.00K
Worse than ADAP's capital expenditure of -2.91M.
100.00%
Worse than ADAP's capex as percentage of revenue of -73.42%.
4.99%
Better than ADAP's weighted average cost of capital (wacc) of 6.28%.
5.02%
Better than ADAP's cost of equity of 17.51%.
4.08%
Better than ADAP's cost of debt of 4.51%.
-0.23
Better than ADAP's beta of 2.85.
30.07M
Better than ADAP's diluted shares outstanding of 42.05M.
1.57M
Better than ADAP's total debt of 74.21M.
49.31M
Better than ADAP's total equity of 11.69M.
50.89M
Worse than ADAP's total capital of 85.89M.
3.09%
Better than ADAP's debt weighting of 86.40%.
96.91%
Better than ADAP's equity weighting of 13.60%.
-22.04M
Better than ADAP's ebiat of -133.63M.
-17.50M
Better than ADAP's unlevered free cash flow of -124.72M.
2.00%
Equal to ADAP's long-term growth rate of 2.00%.
No Data
No DCF data available for this metric in the selected year.
No Data
No DCF data available for this metric in the selected year.
-71.33M
Better than ADAP's net debt of -16.93M.
71.33M
Better than ADAP's equity value of -75.14B.
2.37
Better than ADAP's equity value per share of -1786.98.